KR100562077B1 - 피부보호, 피부 트러블 방지, 피부 유해균 성장억제, 여드름 예방 및 항균특성을 가지는 석류피 추출물의 제조방법 및 그 제조방법으로부터 제조된 석류피 추출물을 함유하는 피부외용 항균조성물 - Google Patents
피부보호, 피부 트러블 방지, 피부 유해균 성장억제, 여드름 예방 및 항균특성을 가지는 석류피 추출물의 제조방법 및 그 제조방법으로부터 제조된 석류피 추출물을 함유하는 피부외용 항균조성물 Download PDFInfo
- Publication number
- KR100562077B1 KR100562077B1 KR1020030065703A KR20030065703A KR100562077B1 KR 100562077 B1 KR100562077 B1 KR 100562077B1 KR 1020030065703 A KR1020030065703 A KR 1020030065703A KR 20030065703 A KR20030065703 A KR 20030065703A KR 100562077 B1 KR100562077 B1 KR 100562077B1
- Authority
- KR
- South Korea
- Prior art keywords
- skin
- pomegranate extract
- pomegranate
- antimicrobial
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940109529 pomegranate extract Drugs 0.000 title claims abstract description 39
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 22
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 title claims abstract description 12
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 9
- 206010000496 acne Diseases 0.000 title claims abstract description 9
- 230000000845 anti-microbial effect Effects 0.000 title claims description 29
- 241000894006 Bacteria Species 0.000 title claims description 13
- 230000002265 prevention Effects 0.000 title description 5
- 230000009036 growth inhibition Effects 0.000 title description 2
- 235000014360 Punica granatum Nutrition 0.000 claims abstract description 11
- 241000186427 Cutibacterium acnes Species 0.000 claims abstract description 5
- 241000219991 Lythraceae Species 0.000 claims abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 32
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 11
- 239000003755 preservative agent Substances 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 9
- 230000002335 preservative effect Effects 0.000 claims description 9
- 239000003963 antioxidant agent Substances 0.000 claims description 6
- 230000003078 antioxidant effect Effects 0.000 claims description 5
- 239000000049 pigment Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000002798 polar solvent Substances 0.000 claims description 4
- 239000004909 Moisturizer Substances 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000003205 fragrance Substances 0.000 claims description 3
- 230000001333 moisturizer Effects 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- 239000002562 thickening agent Substances 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 2
- 208000020154 Acnes Diseases 0.000 claims 2
- NZASCBIBXNPDMH-UHFFFAOYSA-N 3,3-diethyl-1H-pyridine-2,4-dione Chemical compound CCC1(CC)C(=O)NC=CC1=O NZASCBIBXNPDMH-UHFFFAOYSA-N 0.000 claims 1
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 229940055019 propionibacterium acne Drugs 0.000 claims 1
- 210000003491 skin Anatomy 0.000 abstract description 42
- 230000000694 effects Effects 0.000 abstract description 13
- 239000000284 extract Substances 0.000 abstract description 9
- 230000002500 effect on skin Effects 0.000 abstract description 5
- 239000002537 cosmetic Substances 0.000 abstract description 4
- 210000002615 epidermis Anatomy 0.000 abstract description 4
- 241000588724 Escherichia coli Species 0.000 abstract description 3
- 238000012935 Averaging Methods 0.000 abstract 1
- 241000589516 Pseudomonas Species 0.000 abstract 1
- 241000191967 Staphylococcus aureus Species 0.000 abstract 1
- 230000003796 beauty Effects 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 17
- 230000007794 irritation Effects 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 244000294611 Punica granatum Species 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000008213 purified water Substances 0.000 description 8
- 235000013599 spices Nutrition 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 239000006210 lotion Substances 0.000 description 5
- 239000000344 soap Substances 0.000 description 5
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 239000000419 plant extract Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- 241000041995 Pelargonium ovale Species 0.000 description 3
- 206010035502 Plasmodium ovale infection Diseases 0.000 description 3
- -1 Polyoxyethylene Lauryl Ether Polymers 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 241001480043 Arthrodermataceae Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- JEIZLWNUBXHADF-UHFFFAOYSA-N Pelletierine Chemical compound CC(=O)CC1CCCCN1 JEIZLWNUBXHADF-UHFFFAOYSA-N 0.000 description 2
- 229920000864 Punicalin Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000021438 curry Nutrition 0.000 description 2
- 239000007933 dermal patch Substances 0.000 description 2
- 230000037304 dermatophytes Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 229950008882 polysorbate Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- IQHIEHIKNWLKFB-ITTSEVFZSA-N pumcalin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1OC(=O)C1=CC(O)=C(O)C(O)=C11)O)O)OC(=O)C2=CC(O)=C(O)C(O)=C2C2=C(O)C(O)=C(OC3=O)C4=C2C(=O)OC2=C4C3=C1C(O)=C2O IQHIEHIKNWLKFB-ITTSEVFZSA-N 0.000 description 2
- SSIRGMIVWUBXFB-UHFFFAOYSA-N punicalin Natural products OC1OC2COC(=O)c3cc(O)c(O)c(O)c3c4c(O)c(O)c5OC(=O)c6c(c(O)c(O)c7OC(=O)c4c5c67)c8cc(C(=O)OC2C(O)C1O)c(O)c(O)c8O SSIRGMIVWUBXFB-UHFFFAOYSA-N 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- DSJDDPQZEHCNRB-UHFFFAOYSA-N CC(O)=O.[N-2]CC[N-2].[Na+].[Na+].[Na+].[Na+] Chemical compound CC(O)=O.[N-2]CC[N-2].[Na+].[Na+].[Na+].[Na+] DSJDDPQZEHCNRB-UHFFFAOYSA-N 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- AXISYYRBXTVTFY-UHFFFAOYSA-N Isopropyl tetradecanoate Chemical group CCCCCCCCCCCCCC(=O)OC(C)C AXISYYRBXTVTFY-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920000241 Punicalagin Polymers 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 206010059516 Skin toxicity Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical group 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 239000013630 prepared media Substances 0.000 description 1
- 230000003405 preventing effect Effects 0.000 description 1
- ZJVUMAFASBFUBG-OGJBWQGYSA-N punicalagin Chemical compound C([C@H]1O[C@@H]([C@@H]2OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)O[C@H]2[C@@H]1OC(=O)C1=CC(O)=C(O)C(O)=C11)O)OC(=O)C2=CC(O)=C(O)C(O)=C2C2=C(O)C(O)=C(OC3=O)C4=C2C(=O)OC2=C4C3=C1C(O)=C2O ZJVUMAFASBFUBG-OGJBWQGYSA-N 0.000 description 1
- LMIBIMUSUFYFJN-RSVYENFWSA-N punicalagin Natural products O[C@@H]1O[C@@H]2COC(=O)c3cc(O)c(O)c(O)c3c4c(O)cc5OC(=O)c6c(c(O)c(O)c7OC(=O)c4c5c67)c8c(O)c(O)c(O)cc8C(=O)O[C@H]2[C@@H]9OC(=O)c%10cc(O)c(O)c(O)c%10c%11c(O)c(O)c(O)cc%11C(=O)O[C@@H]19 LMIBIMUSUFYFJN-RSVYENFWSA-N 0.000 description 1
- ZRKSVMFLACVUIU-UHFFFAOYSA-N punicalagin isomer Natural products OC1=C(O)C(=C2C3=4)OC(=O)C=4C4=C(O)C(O)=C3OC(=O)C2=C1C1=C(O)C(O)=C(O)C=C1C(=O)OC1C2OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(O)OC1COC(=O)C1=CC4=C(O)C(O)=C1O ZRKSVMFLACVUIU-UHFFFAOYSA-N 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 244000005714 skin microbiome Species 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 231100000438 skin toxicity Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229960004418 trolamine Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
시험균주 | 최소억제농도 |
E. coli | 300 |
P. epidermis | 200 |
S. aeurus | 90 |
P. ovale | 100 |
P. acnes | 180 |
미생물 | 저지환 | 벤조일 퍼옥사이드(대조군) |
E. coli | 1.2 | 0.8 |
P. epidermis | 0.9 | 0.7 |
S. aeurus | 1.0 | 0.5 |
P. ovale | 1.5 | 1.8 |
P. acnes | 1.0 | 1.5 |
실시 예 | 피부첩포 시험결과(자극지수) |
실시 예 1 | 무자극(0.0) |
실시 예 2 | 무자극(0.0) |
실시 예 3 | 무지극(0.0) |
실시 예 4 | 무자극(0.0) |
실시 예 5 | 무자극(0.0) |
실시 예 6 | 무자극(0.2) |
실시 예 7 | 무자극(0.5) |
실시 예 8 | 무자극(0.6) |
실시 예 9 | 무자극(0.0) |
실시 예 10 | 무자극(0.5) |
실시 예 11 | 무자극(0.5) |
Claims (4)
- 수확, 건조하여 세절한 석류피에 5∼10배량의 메탄올, 에탄올 혹은 아세톤 등의 극성 용매를 가하여 10∼14일간 실온에서 침적하여 추출 여과하거나, 50∼60℃의 온도를 가하여 1∼5시간 가온하여 추출 여과하는 단계와;상기 여과액을 감압 증발하여 농축물을 얻어내는 단계를 포함하는 것을 특징으로 하는 피티로스포룸 오발레균(Pityrosporum ovale) 및 피로피오니 박테리움 아크네균(Propionibacterium acnes)에 대하여 항균활성을 나타내는 석류피 추출물의 제조방법.
- 제 1항의 제조방법에 따라 제조된 석류피 추출물이 피부외용제의 전체중량 0.01∼5%를 함유된 것을 특징으로 하는 석류피 추출물을 함유하는 피티로스포룸 오발레균(Pityrosporum ovale) 및 피로피오니 박테리움 아크네균(Propionibacterium acnes)에 대하여 항균활성을 나타내는 피부외용 항균조성물.
- 삭제
- 제 2항에 있어서, 상기 석류피 추출물 이외에도, 유분, 계면활성제, 보습제, 점증제, 방부제, 산화방지제, 향료 및 색소들이 더 포함됨을 특징으로 하는 석류피 추출물을 함유하는 피티로스포룸 오발레균(Pityrosporum ovale) 및 피로피오니 박테리움 아크네균(Propionibacterium acnes)에 대하여 항균활성을 나타내는 피부외용 항균조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030065703A KR100562077B1 (ko) | 2003-09-22 | 2003-09-22 | 피부보호, 피부 트러블 방지, 피부 유해균 성장억제, 여드름 예방 및 항균특성을 가지는 석류피 추출물의 제조방법 및 그 제조방법으로부터 제조된 석류피 추출물을 함유하는 피부외용 항균조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030065703A KR100562077B1 (ko) | 2003-09-22 | 2003-09-22 | 피부보호, 피부 트러블 방지, 피부 유해균 성장억제, 여드름 예방 및 항균특성을 가지는 석류피 추출물의 제조방법 및 그 제조방법으로부터 제조된 석류피 추출물을 함유하는 피부외용 항균조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20050029442A KR20050029442A (ko) | 2005-03-28 |
KR100562077B1 true KR100562077B1 (ko) | 2007-04-12 |
Family
ID=37386034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020030065703A Expired - Lifetime KR100562077B1 (ko) | 2003-09-22 | 2003-09-22 | 피부보호, 피부 트러블 방지, 피부 유해균 성장억제, 여드름 예방 및 항균특성을 가지는 석류피 추출물의 제조방법 및 그 제조방법으로부터 제조된 석류피 추출물을 함유하는 피부외용 항균조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100562077B1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101521446B1 (ko) * | 2013-09-04 | 2015-05-22 | (주) 메디플랜 | 화피, 석류피 또는 염부수백피 추출물을 포함하는 여드름 치료용 조성물 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060036168A (ko) * | 2004-10-25 | 2006-04-28 | 백성기 | 석류피추출물을 함유한 질세정제 조성물 및 그 제조방법 |
KR100747415B1 (ko) * | 2006-02-03 | 2007-08-07 | 보령메디앙스 주식회사 | 여성 젖몸살 완화 효과가 있는 추출혼합물을 함유하는화장료 조성물 |
KR100884258B1 (ko) * | 2007-08-14 | 2009-02-25 | (주)에스디생명공학 | 모공 수축과 피지조절을 위한 식물 추출물을 함유한 팩조성물 |
KR102228126B1 (ko) * | 2019-10-24 | 2021-03-15 | 박성민 | 두피질환 개선용 천연 한방 조성물 및 그 제조방법 |
CN119564540A (zh) * | 2025-01-24 | 2025-03-07 | 拉芳家化股份有限公司 | 一种改善头皮痘痘组合物及其制备工艺及应用 |
-
2003
- 2003-09-22 KR KR1020030065703A patent/KR100562077B1/ko not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101521446B1 (ko) * | 2013-09-04 | 2015-05-22 | (주) 메디플랜 | 화피, 석류피 또는 염부수백피 추출물을 포함하는 여드름 치료용 조성물 |
Also Published As
Publication number | Publication date |
---|---|
KR20050029442A (ko) | 2005-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2531597T3 (es) | Procedimiento de tratamiento de la piel con extracto de Lactobacillus | |
KR101864409B1 (ko) | 한방 추출물 및 미생물 발효추출물을 유효성분으로 함유하는 항균, 살균 또는 항진균용 조성물 | |
KR20090097406A (ko) | 1,2-헥산디올로 추출된 식물추출물을 유효성분으로함유하는 피부 외용제용 보존제 및 상기 보존제를 함유하는화장료 조성물 | |
KR101634668B1 (ko) | 겨우살이의 발효된 추출물을 포함하는 항산화 또는 미백용 화장료 조성물 | |
KR102065185B1 (ko) | 항균, 항염, 피부주름 개선, 및 피부 미백 활성을 갖는 피부상태 개선용 조성물 | |
JP2000247864A (ja) | 化粧料組成物 | |
KR20170040002A (ko) | 홍삼 에탄올 추출물의 부탄올 분획물을 포함하는 여드름 개선용 화장료 조성물 | |
KR102059392B1 (ko) | 정향, 히비스커스, 및 코코넛 추출물을 유효성분으로 포함하는 항균 및 항진균 조성물 | |
CN108014032A (zh) | 一种护臀湿巾及其制备方法 | |
KR100562077B1 (ko) | 피부보호, 피부 트러블 방지, 피부 유해균 성장억제, 여드름 예방 및 항균특성을 가지는 석류피 추출물의 제조방법 및 그 제조방법으로부터 제조된 석류피 추출물을 함유하는 피부외용 항균조성물 | |
KR101383519B1 (ko) | 항균 효과가 우수한 조성물, 이를 제조하는 방법 및 이를 포함하는 화장료 조성물 | |
CN108125797A (zh) | 一种手口湿巾及其制备方法 | |
KR101121615B1 (ko) | 항균용 세정제 조성물 | |
KR20210048021A (ko) | 당귤껍질 추출물, 후박 추출물 및 폴리리신을 포함하는 항균용 조성물 | |
KR102172224B1 (ko) | 인삼 발효 추출물을 유효성분으로 함유하여 황색포도상구균에 대한 항균 활성을 갖는 조성물 | |
KR20130143241A (ko) | 연교, 하고초, 산사, 목통 추출물로 이루어지는 복합 천연방부제 및 이를 유효성분으로 포함하는 화장료 조성물 | |
KR102228086B1 (ko) | 소취 및 암모니아 악취 제거 효과와 항균 효과를 갖는 염모제 조성물 | |
KR20070065926A (ko) | 항균 및 소취 효과를 가지는 녹차 추출물 및 브로컬리추출물을 유효성분으로 포함하는 조성물 및 이의 용도 | |
KR102162904B1 (ko) | 항균, 피부 자극 완화, 소취 및 암모니아 악취제거에 효과를 갖는 염모제 조성물 및 제조방법 | |
KR20050081550A (ko) | 식물 추출물을 함유한 여드름 피부용 저자극 화장료 조성물 | |
KR102630903B1 (ko) | 신규 용도 | |
KR101598194B1 (ko) | 헤어 및 바디용 다기능 소취 화장료 조성물 | |
KR20230080174A (ko) | 미성숙 탱자 열매 추출물을 포함하는 항산화, 항염증 및 여드름의 예방 및 치료용 조성물 | |
KR100787634B1 (ko) | 방부 활성을 가지는 화장료 조성물 | |
JP3501855B2 (ja) | ジャックフルーツ抽出物含有抗菌・防腐剤及び化粧料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20030922 |
|
PA0201 | Request for examination | ||
AMND | Amendment | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20050530 Patent event code: PE09021S01D |
|
AMND | Amendment | ||
E601 | Decision to refuse application | ||
PE0601 | Decision on rejection of patent |
Patent event date: 20060119 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20050530 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
PJ0201 | Trial against decision of rejection |
Patent event date: 20060127 Comment text: Request for Trial against Decision on Refusal Patent event code: PJ02012R01D Patent event date: 20060119 Comment text: Decision to Refuse Application Patent event code: PJ02011S01I Appeal kind category: Appeal against decision to decline refusal Decision date: 20060308 Appeal identifier: 2006101000778 Request date: 20060127 |
|
PB0901 | Examination by re-examination before a trial |
Comment text: Amendment to Specification, etc. Patent event date: 20060127 Patent event code: PB09011R02I Comment text: Request for Trial against Decision on Refusal Patent event date: 20060127 Patent event code: PB09011R01I Comment text: Amendment to Specification, etc. Patent event date: 20051028 Patent event code: PB09011R02I Comment text: Amendment to Specification, etc. Patent event date: 20030926 Patent event code: PB09011R02I |
|
B701 | Decision to grant | ||
PB0701 | Decision of registration after re-examination before a trial |
Patent event date: 20060308 Comment text: Decision to Grant Registration Patent event code: PB07012S01D Patent event date: 20060303 Comment text: Transfer of Trial File for Re-examination before a Trial Patent event code: PB07011S01I |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20060310 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20060313 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20090310 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20100311 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20110308 Start annual number: 6 End annual number: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20120309 Start annual number: 7 End annual number: 7 |
|
FPAY | Annual fee payment |
Payment date: 20130308 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20130308 Start annual number: 8 End annual number: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140307 Year of fee payment: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20140307 Start annual number: 9 End annual number: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150224 Year of fee payment: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20150224 Start annual number: 10 End annual number: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160404 Year of fee payment: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20160404 Start annual number: 11 End annual number: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170308 Year of fee payment: 12 |
|
PR1001 | Payment of annual fee |
Payment date: 20170308 Start annual number: 12 End annual number: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180312 Year of fee payment: 13 |
|
PR1001 | Payment of annual fee |
Payment date: 20180312 Start annual number: 13 End annual number: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190226 Year of fee payment: 14 |
|
PR1001 | Payment of annual fee |
Payment date: 20190226 Start annual number: 14 End annual number: 14 |
|
FPAY | Annual fee payment |
Payment date: 20200224 Year of fee payment: 15 |
|
PR1001 | Payment of annual fee |
Payment date: 20200224 Start annual number: 15 End annual number: 15 |
|
PR1001 | Payment of annual fee |
Payment date: 20210304 Start annual number: 16 End annual number: 16 |
|
PR1001 | Payment of annual fee |
Payment date: 20230223 Start annual number: 18 End annual number: 18 |